[go: up one dir, main page]

DK296190A - Trans-(+)-stereoisomere af pyrimidooe4,5-gaaquinolin-derivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske formuleringer indeholdende saadanne forbindelser - Google Patents

Trans-(+)-stereoisomere af pyrimidooe4,5-gaaquinolin-derivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske formuleringer indeholdende saadanne forbindelser Download PDF

Info

Publication number
DK296190A
DK296190A DK296190A DK296190A DK296190A DK 296190 A DK296190 A DK 296190A DK 296190 A DK296190 A DK 296190A DK 296190 A DK296190 A DK 296190A DK 296190 A DK296190 A DK 296190A
Authority
DK
Denmark
Prior art keywords
gaaquinoline
stereoisomers
trans
derivatives
compounds
Prior art date
Application number
DK296190A
Other languages
English (en)
Other versions
DK296190D0 (da
DK169622B1 (da
Inventor
Cynthia Lynn Nichols
Edmund Carl Kornfield
Mark Mortensen Foreman
John Mehnert Schaus
Diane Lynn Huser
Richard Nolan Booher
David Taiwai Wong
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/535,474 external-priority patent/US4521421A/en
Priority claimed from US06/535,503 external-priority patent/US4501890A/en
Priority claimed from US06/575,126 external-priority patent/US4528290A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK296190D0 publication Critical patent/DK296190D0/da
Publication of DK296190A publication Critical patent/DK296190A/da
Application granted granted Critical
Publication of DK169622B1 publication Critical patent/DK169622B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK296190A 1983-09-26 1990-12-13 Trans-(+)-stereoisomere af pyrimido[4,5-g]quinolin-derivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske formuleringer indeholdende sådanne forbindelser DK169622B1 (da)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US53551983A 1983-09-26 1983-09-26
US06/535,474 US4521421A (en) 1983-09-26 1983-09-26 Treatment of sexual dysfunction
US06/535,503 US4501890A (en) 1983-09-26 1983-09-26 Trans-(±)-2,4,6-substituted-5,5a,6,7,8,9,9a,10-octahydro-pyrimido[4,5-g]quinolines
US53551983 1983-09-26
US53547483 1983-09-26
US53550383 1983-09-26
US06/575,126 US4528290A (en) 1984-01-30 1984-01-30 Stimulating dopamine D-1 receptors
US57512684 1984-01-30
US60609184A 1984-05-02 1984-05-02
US60609184 1984-05-02

Publications (3)

Publication Number Publication Date
DK296190D0 DK296190D0 (da) 1990-12-13
DK296190A true DK296190A (da) 1990-12-13
DK169622B1 DK169622B1 (da) 1994-12-27

Family

ID=27541855

Family Applications (4)

Application Number Title Priority Date Filing Date
DK400984A DK164867C (da) 1983-09-26 1984-08-22 Pyrimidooe4,5-gaaquinolin-derivater eller salte deraf og farmaceutiske formuleringer indeholdende disse
DK296190A DK169622B1 (da) 1983-09-26 1990-12-13 Trans-(+)-stereoisomere af pyrimido[4,5-g]quinolin-derivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske formuleringer indeholdende sådanne forbindelser
DK296290A DK169970B1 (da) 1983-09-26 1990-12-13 Mellemprodukter til brug ved fremstilling af pyrimido[4,5-g]quinolin-derivater eller salte deraf
DK296390A DK169948B1 (da) 1983-09-26 1990-12-13 Mellemprodukter til brug ved fremstilling af pyrimido[4,5-g]quinolin-derivater eller salte deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK400984A DK164867C (da) 1983-09-26 1984-08-22 Pyrimidooe4,5-gaaquinolin-derivater eller salte deraf og farmaceutiske formuleringer indeholdende disse

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK296290A DK169970B1 (da) 1983-09-26 1990-12-13 Mellemprodukter til brug ved fremstilling af pyrimido[4,5-g]quinolin-derivater eller salte deraf
DK296390A DK169948B1 (da) 1983-09-26 1990-12-13 Mellemprodukter til brug ved fremstilling af pyrimido[4,5-g]quinolin-derivater eller salte deraf

Country Status (16)

Country Link
EP (1) EP0139393B1 (da)
JP (1) JPH01151581A (da)
AU (2) AU569539B2 (da)
CY (1) CY1495A (da)
DE (1) DE3484583D1 (da)
DK (4) DK164867C (da)
FI (1) FI78091C (da)
GB (1) GB2146985B (da)
GR (1) GR80201B (da)
HK (1) HK98789A (da)
IE (1) IE57848B1 (da)
IL (1) IL72730A (da)
NZ (1) NZ209295A (da)
PT (1) PT79112B (da)
RO (1) RO89126A (da)
SG (1) SG46389G (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL75992A0 (en) * 1984-08-03 1985-12-31 Lilly Co Eli Improvements in or relating to tricyclic quinoline derivatives
US4764609A (en) * 1986-03-31 1988-08-16 Eli Lilly And Company Synthesis of 2-aminopyrimido[4,5-g]quinolines
US4826986A (en) * 1986-06-16 1989-05-02 Eli Lilly And Company 6-Oxo-trans-octa- and decahydroquinolines
US4762843A (en) * 1986-09-15 1988-08-09 Warner-Lambert Company Hetero [f] fused carbocyclic pyridines as dopaminergic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198415A (en) * 1979-01-22 1980-04-15 Eli Lilly And Company Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines
JPS59202892A (ja) * 1983-05-04 1984-11-16 Ricoh Co Ltd 光学的情報記録媒体
US4507478A (en) * 1983-09-26 1985-03-26 Eli Lilly And Company 2-Mercaptopyrimidohexahydroquinolines and related compounds
IL75992A0 (en) * 1984-08-03 1985-12-31 Lilly Co Eli Improvements in or relating to tricyclic quinoline derivatives

Also Published As

Publication number Publication date
GB2146985A (en) 1985-05-01
FI843282A0 (fi) 1984-08-20
DK296190D0 (da) 1990-12-13
AU3228084A (en) 1985-04-04
DK164867B (da) 1992-08-31
DK296390D0 (da) 1990-12-13
JPH0529398B2 (da) 1993-04-30
IE842154L (en) 1985-03-26
IE57848B1 (en) 1993-04-21
DE3484583D1 (de) 1991-06-20
RO89126A (ro) 1986-04-30
SG46389G (en) 1989-12-22
IL72730A0 (en) 1984-11-30
AU8216887A (en) 1988-03-31
PT79112A (en) 1984-09-01
AU585473B2 (en) 1989-06-15
FI843282A (fi) 1985-03-27
DK400984A (da) 1985-03-27
CY1495A (en) 1990-02-16
JPH01151581A (ja) 1989-06-14
GB8421160D0 (en) 1984-09-26
GB2146985B (en) 1987-05-28
DK296390A (da) 1990-12-13
DK296290D0 (da) 1990-12-13
DK169948B1 (da) 1995-04-10
GR80201B (en) 1985-01-02
DK169970B1 (da) 1995-04-18
DK400984D0 (da) 1984-08-22
HK98789A (en) 1989-12-22
EP0139393B1 (en) 1991-05-15
DK296290A (da) 1990-12-13
DK164867C (da) 1993-11-08
PT79112B (en) 1986-11-14
AU569539B2 (en) 1988-02-04
FI78091C (fi) 1989-06-12
IL72730A (en) 1987-10-30
DK169622B1 (da) 1994-12-27
EP0139393A3 (en) 1988-01-13
NZ209295A (en) 1987-05-29
EP0139393A2 (en) 1985-05-02
FI78091B (fi) 1989-02-28

Similar Documents

Publication Publication Date Title
DK164450C (da) Alkylsulfonamidophenylalkylaminer eller syreadditionssalte deraf, farmaceutiske formuleringer indeholdende saadanne forbindelser og fremgangsmaade til fremstilling af forbindelserne
DK146482A (da) Fremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK445084D0 (da) 6-flour-1,4-dihydro-4-oxo-7-substituerede piperazinylquinolin-3-carboxylsyrederivater, fremgangsmaade til fremstilling af samme og farcaceutiske sammensaetninger indeholdende samme
MX9203177A (es) Derivados de 1-fluorofenilbutil-4-(2-pirimidinil)piperazina y composiciones farmaceuticas que los contienen.
DK164543C (da) Salte af l-carnitin og alkanoyl-l-carnitiner, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK190885D0 (da) 2-(n-substitueret guanidino)-4-heteroarylthiazolderivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutisk praeparat indeholdende forbindelserne
DK159848C (da) 7-hydroxy-1,2,3,4,4a,5,6,10b-oktahydrobenzo(f)-quinoliner eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske praeparater indeholdende saadanne forbindelser
DK112287A (da) Anvendelse af 2-alkoxy-n-(1-azabicyclo-oe2,2,2aaoct-3-yl)-benzamider og -thiobenzamider samt farmaceutisk acceptable syreadditionssalte deraf som laegemidler
DK319884D0 (da) Fremgangsmaader til fremstilling af 9a-ethyl- og 9a-n-propylderivater af 9-deoxo-9a-aza-9a-homoerythromycin a eller syreadditionssalte deraf
DK164109C (da) Lh-rh-antagonister og deres farmaceutisk acceptable syreadditionssalte og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende disse
FI871188A0 (fi) Anordning foer faestning av ett verktyg vid en haollare.
DK160873C (da) Benzoquinolizinderivater samt farmaceutisk acceptable syreadditionssalte deraf og farmaceutisk middel indeholdende saadanne forbindelser og dettes fremstilling
DK296190A (da) Trans-(+)-stereoisomere af pyrimidooe4,5-gaaquinolin-derivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske formuleringer indeholdende saadanne forbindelser
DK438482A (da) Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
DK202286A (da) Dihydropyridin-forbindelser og deres anvendelse til fremstilling af antiisohaemiske eller antihypertensive midler samt farmaceutiske praeparater indeholdende forbindelserne
DK157023C (da) Analogifremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK386783A (da) Fremgangsmaade til fremstilling af benzamidderivater eller et farmaceutisk acceptabelt salt deraf
DK586284D0 (da) Quinoloncarboxylsyre-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne derivater som laegemiddel
DK610084A (da) Imidazolderivater eller syreadditionssalte deraf, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
DK553982A (da) Fremgangsmaade til fremstilling af omt-esterderivater eller syreadditionssalte deraf
DK628086D0 (da) Pyrazinderivater og farmaceutisk acceptable salte heraf samt fremgangsmaade til fremstilling af og farmaceutisk komposition indeholdende samme
DK313285A (da) Ether af et n-propylaminderivat og syreadditionssalte deraf, fremgangsmaade til deres fremstilling samt farmaceutisk middel indeholdendedisse forbindelser
DK454987D0 (da) 2,3-dihydro-1h-phenalen-2-aminoforbindelser eller syreadditionssalte deraf samt farmaceutiske praeparater indeholdende dem
DK160299C (da) Basiske 2-fenylenmetylen-cykloalkanoximaetere eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske praeparater indeholdende saadanne forbindelser
DK299983A (da) Racemiske eller optisk aktive apovincaminsyrederivater eller farmaceutisk aktive syreadditionssalte deraf, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed